O. Reg. 444/01: GENERAL, Filed November 30, 2001 under Workplace Safety and Insurance Act, 1997, S.O. 1997, c. 16, Sched. A
ontario regulation 444/01
made under the
workplace safety and
insurance act, 1997
Made: October 22, 2001
Approved: November 28, 2001
Filed: November 30, 2001
Printed in The Ontario Gazette: December 15, 2001
Amending O. Reg. 175/98
(General)
1. Section 1 of Ontario Regulation 175/98 is amended by adding the following definition:
“manufacturing” includes making, preparing, altering, repairing, ornamenting, printing, finishing, packing, packaging, inspecting, testing, assembling the parts of and adapting for use or sale any article, commodity or raw material;
2. Items 11 and 12 of Schedule 2 to the Regulation are revoked.
3. Schedule 3 to the Regulation is revoked and the following substituted:
Schedule 3
OCCUPATIONAL DISEASES
Column 1 |
Column 2 |
|
Description of |
Process |
|
Poisoning and its Sequelae |
||
1. |
By arsenic |
Any process involving exposure to or the use of arsenic, arsenic preparations or arsenic compounds |
2. |
By benzene |
Any process involving exposure to or the use of benzene |
3. |
By beryllium |
Any process involving exposure to or the use of beryllium, beryllium preparations or beryllium compounds |
4. |
By brass, nickel or zinc |
Any melting or smelting process involving exposure to brass, nickel or zinc |
5. |
By cadmium |
Any process involving exposure to or the use of cadmium, cadmium preparations or cadmium compounds |
6. |
By carbon dioxide |
Any process involving exposure to carbon dioxide |
7. |
By carbon disulphide |
Any process involving exposure to carbon disulphide |
8. |
By carbon monoxide |
Any process involving exposure to carbon monoxide |
9. |
By chlorinated hydrocarbons |
Any process in the manufacture of, or the use of, or involving exposure to chlorinated hydrocarbons |
10. |
By chromium |
Any process involving exposure to or the use of chromium or chromium compounds |
11. |
By lead |
Any process involving exposure to or the use of lead, lead preparations or lead compounds |
12. |
By mercury |
Any process involving exposure to or the use of mercury, mercury preparations or mercury compounds |
13. |
By nitro- or amino- derivatives of benzene, phenol or their homologues |
Any process involving manufacture, handling, use or exposure to nitro- or amino- derivatives of benzene, phenol or their homologues |
14. |
By oxides of nitrogen |
Any process involving exposure to oxides of nitrogen |
15. |
By phosphorous |
Any process involving exposure to or the use of phosphorus |
Diseases from Biological Agents |
||
16. |
Anthrax |
Handling of animals and animal parts, or any other process that results in exposure to a source of anthrax infection |
17. |
Tuberculosis |
Any employment in a health care facility, a laboratory as defined in the Laboratory and Specimen Collection Centre Licensing Act or a reform institution, any employment in providing health care services or health care support services or any |
|
|
other employment in which there is a known risk of exposure to tuberculosis or to the tubercle bacillus |
Diseases from Physical Agents |
||
18. |
Bursitis |
Any process involving constant or prolonged friction to or pressure on the bursae |
19. |
Infected blisters |
Any process involving friction to the skin that creates opportunity for infection |
20. |
Tenosynovitis |
Any process involving continual or repetitive injury to tendons of the limbs |
21. |
Dysbarism: decompression sickness including caisson disease |
Any process involving work in compressed or decompressed air |
22. |
Any disease due to exposure to X-rays, radium or other radioactive substances |
|
Respiratory Diseases |
||
23. |
Asthma |
Any process involving exposure to allergenic non-offset sprays in the printing industry |
24. |
Silicosis |
Any process involving exposure to crystalline silica |
25. |
Pneumoconioses other than silicosis or asbestosis |
Any process involving exposure to the relevant dust |
Skin and Eye Diseases |
||
26. |
Allergic contact dermatitis |
Any process involving exposure to a skin allergen |
27. |
Ulceration of the skin or cornea |
Any process involving use, handling, or exposure to tar, pitch, bitumen, mineral oil or paraffin or any compound, product or residue of these substances |
28. |
Photo keratoconjunctivitis and photo retinitis |
Any process involving prolonged or intense ultra-violet or infra-red exposure, including gas or arc welding or use of lasers |
Cancer |
||
29. |
Epitheliomatous (skin) cancer |
Any process involving use or handling of tar pitch, bitumen, mineral oil or paraffin or any compound, product or residue of these substances |
30. |
Primary cancer of the nasal cavities or of paranasal sinuses |
Concentrating, smelting or refining in the nickel producing industry |
4. (1) Subject to subsection (2), this Regulation comes into force on filing.
(2) Section 2 comes into force on January 1, 2002.
Workplace Safety and Insurance Board:
Glen Wright
Chair
Linda Angove
Secretary
Dated on October 22, 2001.